CH681425A5
(de)
*
|
1990-11-14 |
1993-03-31 |
Debio Rech Pharma Sa |
|
DE4120760A1
(de)
*
|
1991-06-24 |
1993-03-04 |
3 M Medica Gmbh |
Traegersysteme fuer arzneimittel
|
FI101039B
(fi)
*
|
1992-10-09 |
1998-04-15 |
Eeva Kristoffersson |
Menetelmä lääkepellettien valmistamiseksi
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6284727B1
(en)
*
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
NZ250844A
(en)
*
|
1993-04-07 |
1996-03-26 |
Pfizer |
Treatment of non-insulin dependant diabetes with peptides; composition
|
ES2236700T3
(es)
|
1993-11-19 |
2005-07-16 |
Janssen Pharmaceutica N.V. |
1,2-benzazoles microencapsulados.
|
US5902565A
(en)
*
|
1993-12-24 |
1999-05-11 |
Csl Limited |
Spray dried vaccine preparation comprising aluminium adsorbed immunogens
|
CA2184242C
(en)
*
|
1994-02-28 |
2000-05-02 |
Jorg Kreuter |
Drug targeting system, method for preparing same and its use
|
DE4414755C2
(de)
*
|
1994-04-27 |
2000-11-16 |
Lohmann Therapie Syst Lts |
Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
|
AUPM572294A0
(en)
*
|
1994-05-18 |
1994-06-09 |
Vaccine Technologies Pty. Ltd. |
Delivery vehicle for bioactive molecule
|
GB9412273D0
(en)
*
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
GB2303551B
(en)
*
|
1994-06-18 |
1998-04-22 |
Univ Nottingham |
Polymer microparticles for drug delivery
|
AUPM855194A0
(en)
*
|
1994-10-04 |
1994-10-27 |
Csl Limited |
Controlled-release pharmaceutical preparations
|
SE9403846D0
(sv)
*
|
1994-11-09 |
1994-11-09 |
Univ Ohio State Res Found |
Small particle formation
|
KR100201352B1
(ko)
*
|
1995-03-16 |
1999-06-15 |
성재갑 |
단일주사 백신 제형
|
ES2093562B1
(es)
*
|
1995-05-26 |
1997-07-01 |
Univ Santiago Compostela |
Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido.
|
US6479457B2
(en)
|
1995-06-06 |
2002-11-12 |
Kinerton Limited |
Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
|
US5665702A
(en)
*
|
1995-06-06 |
1997-09-09 |
Biomeasure Incorporated |
Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
US20050267302A1
(en)
*
|
1995-12-11 |
2005-12-01 |
G.D. Searle & Co. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
US7276251B2
(en)
|
1997-04-01 |
2007-10-02 |
Lg Life Sciences, Ltd., Inc. |
Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
|
KR100236771B1
(ko)
*
|
1997-04-01 |
2000-02-01 |
성재갑 |
히아루론산을 이용한 약물의 서방성 미세입자 제형
|
US5939047A
(en)
*
|
1996-04-16 |
1999-08-17 |
Jernberg; Gary R. |
Local delivery of chemotherapeutic agents for treatment of periodontal disease
|
US5792477A
(en)
*
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
FR2755856B1
(fr)
*
|
1996-11-21 |
1999-01-29 |
Merck Clevenot Laboratoires |
Microcapsules de chitine ou de derives de chitine contenant une substance hydrophobe, notamment un filtre solaire et procede de preparation de telles microcapsules
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
CA2275889C
(en)
|
1996-12-30 |
2008-03-18 |
Battelle Memorial Institute |
Formulation and method for treating neoplasms by inhalation
|
GB9700624D0
(en)
|
1997-01-14 |
1997-03-05 |
Danbiosyst Uk |
Drug delivery composition
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US6443949B2
(en)
*
|
1997-03-13 |
2002-09-03 |
Biocardia, Inc. |
Method of drug delivery to interstitial regions of the myocardium
|
US6511477B2
(en)
*
|
1997-03-13 |
2003-01-28 |
Biocardia, Inc. |
Method of drug delivery to interstitial regions of the myocardium
|
US6350322B1
(en)
*
|
1997-03-21 |
2002-02-26 |
Micron Technology, Inc. |
Method of reducing water spotting and oxide growth on a semiconductor structure
|
US6020004A
(en)
*
|
1997-04-17 |
2000-02-01 |
Amgen Inc. |
Biodegradable microparticles for the sustained delivery of therapeutic drugs
|
GB9710699D0
(en)
|
1997-05-24 |
1997-07-16 |
Danbiosyst Uk |
Gastro-retentive controlled release system
|
WO1998056361A1
(en)
*
|
1997-06-13 |
1998-12-17 |
Medinova Medical Consulting Gmbh |
Drug targeting system, method of its preparation and its use
|
US7135191B2
(en)
*
|
1997-09-04 |
2006-11-14 |
Zsolt Istvan Hertelendy |
Urogenital or anorectal transmucosal vaccine delivery system
|
JP4234803B2
(ja)
*
|
1997-10-27 |
2009-03-04 |
久光製薬株式会社 |
薬物放出速度が制御された医薬組成物
|
IT1298574B1
(it)
*
|
1998-02-06 |
2000-01-12 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione
|
KR100314496B1
(ko)
|
1998-05-28 |
2001-11-22 |
윤동진 |
항혈전성이 있는 헤파린 유도체, 그의 제조방법 및 용도
|
AU5925399A
(en)
*
|
1998-09-16 |
2000-04-03 |
Oncopharmaceutical, Inc. |
Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent
|
US6984404B1
(en)
|
1998-11-18 |
2006-01-10 |
University Of Florida Research Foundation, Inc. |
Methods for preparing coated drug particles and pharmaceutical formulations thereof
|
GB2344287A
(en)
*
|
1998-12-03 |
2000-06-07 |
Ferring Bv |
Controlled release pharmaceutical formulation
|
US6194006B1
(en)
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US6159491A
(en)
*
|
1999-02-12 |
2000-12-12 |
Biovector Technologies, Inc. |
Prolonged release bioadhesive vaginal gel dosage form
|
US6297337B1
(en)
|
1999-05-19 |
2001-10-02 |
Pmd Holdings Corp. |
Bioadhesive polymer compositions
|
US6406745B1
(en)
|
1999-06-07 |
2002-06-18 |
Nanosphere, Inc. |
Methods for coating particles and particles produced thereby
|
KR100698559B1
(ko)
|
1999-06-11 |
2007-03-21 |
넥타르 테라퓨틱스 에이엘, 코포레이션 |
키토산 및 폴리(에틸렌 글리콜) 또는 관련 폴리머로부터유래되는 하이드로겔
|
US6787531B1
(en)
*
|
1999-08-31 |
2004-09-07 |
Schering Ag |
Pharmaceutical composition for use as a contraceptive
|
EP1216043B1
(de)
*
|
1999-10-01 |
2003-05-07 |
Degussa AG |
Alpha-liponsäure(-derivate)enthaltende retardform
|
DE19949897A1
(de)
*
|
1999-10-15 |
2001-04-19 |
Rainer Rogasch |
Formkörper und Verfahren zu dessen Herstellung
|
US6495166B1
(en)
|
1999-11-12 |
2002-12-17 |
Alkermes Controlled Therapeutics Inc. |
Apparatus and method for preparing microparticles using in-line solvent extraction
|
US6331317B1
(en)
|
1999-11-12 |
2001-12-18 |
Alkermes Controlled Therapeutics Ii Inc. |
Apparatus and method for preparing microparticles
|
US6705757B2
(en)
|
1999-11-12 |
2004-03-16 |
Alkermes Controlled Therapeutics, Inc. Ii |
Method and apparatus for preparing microparticles using in-line solvent extraction
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
SK12672001A3
(sk)
*
|
1999-12-08 |
2002-04-04 |
Pharmacia Corporation |
Zloženia inhibítora cyklooxygenázy-2 s rýchlym nástupom terapeutického účinku
|
US20030083493A1
(en)
*
|
1999-12-08 |
2003-05-01 |
Barton Kathleen P. |
Eplerenone drug substance having high phase purity
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
EA008449B1
(ru)
*
|
1999-12-08 |
2007-06-29 |
Фармация Корпорейшн |
Кристаллическая форма эплеренона
|
ES2169980B1
(es)
|
1999-12-17 |
2003-11-01 |
Lipotec Sa |
Microcapsulas para la liberacion prolongada de farmacos.
|
US7785625B2
(en)
|
2000-01-14 |
2010-08-31 |
Lg Life Sciences, Limited |
Lipophilic-coated microparticle containing a protein drug and formulation comprising same
|
EP1251867A4
(de)
|
2000-02-04 |
2004-12-08 |
Unigene Lab Inc |
Nasale calcitoninformulierungen
|
AU2001264706A1
(en)
*
|
2000-05-19 |
2001-12-03 |
Battelle Memorial Institute |
Controlled release of materials from polymer matrices
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
MY120279A
(en)
|
2000-05-26 |
2005-09-30 |
Pharmacia Corp |
Use of a celecoxib composition for fast pain relief
|
EP1292285A4
(de)
*
|
2000-06-02 |
2009-07-22 |
Eisai Corp North America |
Darreichungssystem für bioaktive stoffe
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
DE10036051A1
(de)
*
|
2000-07-25 |
2002-02-07 |
Beiersdorf Ag |
Kosmetische oder dermatologische Formulierungen zur Pflege und Kühlung der Haut nach einem Sonnenbad
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
AU2001296558A1
(en)
|
2000-10-03 |
2002-04-15 |
Oncopharmaceutical, Inc. |
Inhibitors of angiogenesis and tumor growth for local and systemic administration
|
US6576226B1
(en)
|
2000-11-17 |
2003-06-10 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
US6726898B2
(en)
|
2000-11-17 |
2004-04-27 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
AU2002233239B2
(en)
*
|
2000-12-13 |
2006-05-11 |
Merckle Gmbh |
Microparticles with an improved release profile and method for the production thereof
|
EP1343480B2
(de)
|
2000-12-21 |
2016-02-17 |
Alrise Biosystems GmbH |
Verfahren umfassend einen induzierten phasenübergang zur herstellung von hydrophobe wirkstoffe enthaltenden mikropartikeln
|
US20020114843A1
(en)
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
JP5160005B2
(ja)
*
|
2000-12-28 |
2013-03-13 |
武田薬品工業株式会社 |
徐放性製剤
|
WO2002053136A1
(fr)
|
2000-12-28 |
2002-07-11 |
Takeda Chemical Industries, Ltd. |
Preparations a liberation soutenue
|
GB0113841D0
(en)
*
|
2001-06-07 |
2001-08-01 |
Boots Co Plc |
Therapeutic agents
|
GB0121709D0
(en)
*
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
EP2050460A1
(de)
*
|
2001-09-24 |
2009-04-22 |
Imperial Innovations Limited |
PYY und dessen Agonisten zur Änderung des Fütterverhaltens
|
JP2005529060A
(ja)
*
|
2001-09-25 |
2005-09-29 |
ファルマシア コーポレイション |
N−(2−ヒドロキシアセチル)−5−(4−ピペリヂル)−4−(4−ピリミヂニル)−3−(4−クロロフェニル)ピラゾールの固体形態
|
DE60222007T2
(de)
*
|
2001-10-18 |
2008-05-15 |
Samyang Corp. |
Polymermicellenzusammensetzung mit verbesserter stabilität
|
JP4733922B2
(ja)
|
2002-01-10 |
2011-07-27 |
インペリアル・イノベ−ションズ・リミテッド |
摂食行動の修正
|
US8058233B2
(en)
*
|
2002-01-10 |
2011-11-15 |
Oregon Health And Science University |
Modification of feeding behavior using PYY and GLP-1
|
WO2003075892A1
(en)
*
|
2002-03-13 |
2003-09-18 |
Novartis Ag |
Pharmaceutical microparticles
|
WO2003077891A1
(fr)
*
|
2002-03-18 |
2003-09-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
Compositions medicales en poudre pour inhalation et procede de production de celles-ci
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
US6702850B1
(en)
*
|
2002-09-30 |
2004-03-09 |
Mediplex Corporation Korea |
Multi-coated drug-eluting stent for antithrombosis and antirestenosis
|
US7351430B2
(en)
*
|
2002-11-06 |
2008-04-01 |
Uluru Inc. |
Shape-retentive hydrogel particle aggregates and their uses
|
US7811605B2
(en)
*
|
2002-11-06 |
2010-10-12 |
Uluru Inc. |
Method of formation of shape-retentive aggregates of gel particles and their uses
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
US7060299B2
(en)
*
|
2002-12-31 |
2006-06-13 |
Battelle Memorial Institute |
Biodegradable microparticles that stabilize and control the release of proteins
|
GB0300571D0
(en)
*
|
2003-01-10 |
2003-02-12 |
Imp College Innovations Ltd |
Modification of feeding behaviour
|
US20040184995A1
(en)
*
|
2003-03-17 |
2004-09-23 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel dry powder inhalation for lung-delivery and manufacturing method thereof
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
ES2600554T3
(es)
*
|
2003-07-18 |
2017-02-09 |
Oakwood Laboratories L.L.C. |
Prevención de la reducción del peso molecular del polímero, de la formación de impurezas y de la gelificación en composiciones poliméricas
|
EP1660047B1
(de)
*
|
2003-08-13 |
2013-11-27 |
Biocon Limited |
Mikroteilchenförmige fettsäure-salz-festdosis-formulierungen für therapeutische mittel
|
TW200524959A
(en)
*
|
2003-09-08 |
2005-08-01 |
Chugai Pharmaceutical Co Ltd |
Hyaluronic acid modification product and drug carrier therefrom
|
US7901707B2
(en)
*
|
2004-03-15 |
2011-03-08 |
Christine Allen |
Biodegradable biocompatible implant and method of manufacturing same
|
JP2005270891A
(ja)
*
|
2004-03-26 |
2005-10-06 |
Tetsuo Kondo |
多糖類の湿式粉砕方法
|
CN1968700A
(zh)
|
2004-04-15 |
2007-05-23 |
阿尔克姆斯有限公司 |
聚合物基的持续释放装置
|
DK1742616T3
(en)
*
|
2004-04-30 |
2015-01-12 |
Abraxis Bioscience Llc |
The microsphere-discharge-system for the prolonged delivery and methods of making and using the same
|
WO2005112885A2
(en)
*
|
2004-05-12 |
2005-12-01 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
EP1765294B1
(de)
*
|
2004-05-12 |
2008-09-24 |
Baxter International Inc. |
Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
|
GB0412866D0
(en)
*
|
2004-06-09 |
2004-07-14 |
Novartis Ag |
Organic compounds
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
GB0511986D0
(en)
*
|
2005-06-13 |
2005-07-20 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
WO2006134340A2
(en)
|
2005-06-13 |
2006-12-21 |
Imperial Innovations Limited |
Oxyntomodulin analogues and their effects on feeding behaviour
|
US8778395B2
(en)
*
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
KR100718329B1
(ko)
*
|
2005-09-08 |
2007-05-14 |
광주과학기술원 |
다당류로 기능화된 수화젤막을 가지는 나노입자와 이를포함하는 서방형 약물전달시스템 및 그 제조방법
|
DE602007009377D1
(de)
|
2006-05-30 |
2010-11-04 |
Intarcia Therapeutics Inc |
Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
|
KR101200728B1
(ko)
|
2006-08-09 |
2012-11-13 |
인타르시아 세라퓨틱스 인코포레이티드 |
삼투성 전달 시스템 및 피스톤 조립체
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
CA3163418A1
(en)
|
2006-10-06 |
2008-05-22 |
Jeffrey S. Isenberg |
Prevention of tissue ischemia, related methods and compositions
|
US7910135B2
(en)
*
|
2006-10-13 |
2011-03-22 |
Uluru Inc. |
Hydrogel wound dressing and biomaterials formed in situ and their uses
|
TWI428346B
(zh)
|
2006-12-13 |
2014-03-01 |
Imp Innovations Ltd |
新穎化合物及其等對進食行為影響
|
US20080228268A1
(en)
*
|
2007-03-15 |
2008-09-18 |
Uluru, Inc. |
Method of Formation of Viscous, Shape Conforming Gels and Their Uses as Medical Prosthesis
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
BRPI0705072B8
(pt)
*
|
2007-04-27 |
2021-05-25 |
Univ Estadual Campinas Unicamp |
grânulos mucoadesivos contendo nano e/ou microesferas de quitosana e processo de obtenção de grânulos mucoadesivos
|
US10092524B2
(en)
|
2008-06-11 |
2018-10-09 |
Edge Therapeutics, Inc. |
Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
|
RU2506273C2
(ru)
|
2007-07-09 |
2014-02-10 |
Импиэриэл Инноувейшнс Лимитид |
Аналог панкреатического полипептида человека (варианты), фармацевтическая композиция на его основе, способ лечения ожирения или диабета, способ снижения аппетита, уменьшения поглощения пищи или снижения потребления калорий и способ косметического снижения массы посредством указанного аналога
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
US20100021538A1
(en)
*
|
2008-02-29 |
2010-01-28 |
Youngro Byun |
Pharmaceutical compositions containing heparin derivatives
|
US7828996B1
(en)
*
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
SI2462246T1
(en)
|
2009-09-28 |
2018-01-31 |
Intarcia Therapeutics, Inc. |
Fast-setting and / or cessation of substantially unchanged delivery of the product
|
US20120263784A1
(en)
*
|
2009-10-12 |
2012-10-18 |
Lyka Labs Limited |
Emergency contraceptive
|
GB0918579D0
(en)
|
2009-10-22 |
2009-12-09 |
Imp Innovations Ltd |
Gadd45beta targeting agents
|
GB201001333D0
(en)
|
2010-01-27 |
2010-03-17 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
US8685416B2
(en)
|
2010-03-02 |
2014-04-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for the treatment of cancer
|
GB201101459D0
(en)
|
2011-01-27 |
2011-03-16 |
Imp Innovations Ltd |
Novel compounds and thier effects on fedding behaviour
|
BR112013020512A2
(pt)
*
|
2011-02-11 |
2016-09-06 |
Edge Therapeutics |
composições e métodos para melhorar o prognóstico de um humano com hemorragia subaracnóide
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
AU2012240131B2
(en)
|
2011-04-05 |
2017-07-20 |
Edge Therapeutics |
Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
|
US9944687B2
(en)
|
2011-07-04 |
2018-04-17 |
Imperial Innovations Limited |
Compounds and their effects on feeding behaviour
|
RU2607191C2
(ru)
|
2011-07-22 |
2017-01-10 |
Хемоцентрикс, Инк. |
Полиморфные формы натриевой соли 4-трет-бутил-n-[4-хлор-2-(1-окси-пиридин-4-карбонил)-фенил]-бензолсульфонамида
|
JP6122003B2
(ja)
|
2011-07-22 |
2017-04-26 |
ケモセントリックス, インコーポレイテッド |
4−tert−ブチル−N−[4−クロロ−2−(1−オキシ−ピリジン−4−カルボニル)−フェニル]−ベンゼンスルホンアミドのナトリウム塩の結晶形
|
RS57644B1
(sr)
|
2011-09-01 |
2018-11-30 |
Glaxo Group Ltd |
Novi kristalni oblik
|
WO2014160183A1
(en)
|
2013-03-13 |
2014-10-02 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
Methods for modulating chemotherapeutic cytotoxicity
|
WO2014201245A1
(en)
|
2013-06-12 |
2014-12-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors
|
IL242979B2
(en)
|
2013-07-02 |
2023-03-01 |
Cortice Biosciences Inc |
A method for treating degenerative nerve diseases
|
JP6681872B2
(ja)
|
2014-03-21 |
2020-04-15 |
ユニバーシティ オブ ピッツバーグ −オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
細胞外マトリクス由来最終滅菌ヒドロゲルの調製方法
|
CN106456678A
(zh)
|
2014-04-15 |
2017-02-22 |
Ao生物医学有限责任公司 |
氨氧化型亚硝化单胞菌菌株d23
|
EP3131532A1
(de)
|
2014-04-16 |
2017-02-22 |
Veyx-Pharma GmbH |
Veterinärpharmazeutische zusammensetzung und deren verwendung
|
CA2949833A1
(en)
|
2014-05-22 |
2015-11-26 |
Aobiome Llc |
Methods of preparing materials with ammonia oxidizing bacteria and testing materials for ammonia oxidizing bacteria
|
CA2949831A1
(en)
|
2014-05-22 |
2015-11-26 |
Aobiome Llc |
Systems and methods for storage and delivery of ammonia oxidizing bacteria
|
WO2015177572A1
(en)
|
2014-05-23 |
2015-11-26 |
Imperial Innovations Limited |
Peptide yy (pyy) analogues
|
GB201410507D0
(en)
|
2014-06-12 |
2014-07-30 |
Univ Bath |
Drug delivery enhancement agents
|
EA032017B1
(ru)
|
2014-06-25 |
2019-03-29 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Кристаллические соли (s)-6-((1-ацетилпиперидин-4-ил)амино)-n-(3-(3,4-дигидроизохинолин-2(1h)-ил)-2-гидроксипропил)пиримидин-4-карбоксамида
|
WO2016038519A1
(en)
|
2014-09-08 |
2016-03-17 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-n-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
WO2016164412A1
(en)
|
2015-04-07 |
2016-10-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hypoxia-inducible factor 1 (hif-1) inhibitors
|
WO2016183370A1
(en)
|
2015-05-13 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Synthetic immunosuppressive oligodeoxynucleotides reduce ischemic tissue damage
|
WO2016183371A1
(en)
|
2015-05-13 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Methods for the treatment or prevention of ischemic tissue damage
|
KR20240042548A
(ko)
|
2015-06-03 |
2024-04-02 |
인타르시아 세라퓨틱스 인코포레이티드 |
임플란트 배치 및 제거 시스템들
|
WO2017004534A2
(en)
|
2015-07-02 |
2017-01-05 |
Aobiome Llc |
Microbiome-compatible cosmetics
|
AU2016288256B2
(en)
|
2015-07-02 |
2022-08-25 |
Aobiome Llc |
Ammonia oxidizing bacteria for treatment of acne
|
WO2017151862A1
(en)
|
2016-03-02 |
2017-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Matrix bound nanovesicles and their use
|
MA53353A
(fr)
|
2016-05-16 |
2021-06-09 |
Intarcia Therapeutics Inc |
Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
US20190247446A1
(en)
|
2016-07-19 |
2019-08-15 |
Aobiome Llc |
Ammonia oxidizing microorganisms for use and delivery to the gastrointestinal system
|
US20200016216A1
(en)
|
2016-09-21 |
2020-01-16 |
Aobiome Llc |
Ammonia oxidizing microorganisms for use and delivery to the intranasal system
|
RU2649743C1
(ru)
*
|
2016-10-24 |
2018-04-04 |
Станислав Анатольевич Кедик |
Жидкая лекарственная форма, содержащая лекарственное вещество, помещенное в биоразлагаемые полимеры
|
CA3047041A1
(en)
|
2016-12-12 |
2018-06-21 |
Aobiome Llc |
Ammonia oxidizing microorganisms for the regulation of blood pressure
|
EP3565580B1
(de)
|
2017-01-03 |
2024-03-06 |
i2o Therapeutics, Inc. |
Kontinuierlicher verabreichung von exenatid und co-verabreichung von acetaminophen, ethinylestradiol oder levonorgestrel
|
AU2018226871B2
(en)
|
2017-03-02 |
2023-08-10 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Extracellular matrix (ECM) hydrogel and soluble fraction thereof for the treatment of cancer
|
US20200206277A1
(en)
|
2017-06-13 |
2020-07-02 |
Aobiome Llc |
Ammonia oxidizing microorganisms for dispersing biofilms
|
GB201720188D0
(en)
|
2017-12-04 |
2018-01-17 |
Imperial Innovations Ltd |
Analogues of PYY
|
CN108159002B
(zh)
*
|
2018-01-09 |
2020-06-16 |
大连理工大学 |
一种洋葱仿生多层结构可控释药载体的制备方法
|
WO2020186187A1
(en)
|
2019-03-13 |
2020-09-17 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods for treating bladder and urethra dysfunction and disease
|
GB201908424D0
(en)
|
2019-06-12 |
2019-07-24 |
Imp College Innovations Ltd |
Novel compounds
|
GB201908426D0
(en)
|
2019-06-12 |
2019-07-24 |
Imp College Innovations Ltd |
Appetite suppressing compounds
|
US20230210763A1
(en)
*
|
2019-09-19 |
2023-07-06 |
Amw Gmbh |
Extruded depot form for controlled active substance release
|
GB202009007D0
(en)
|
2020-06-12 |
2020-07-29 |
Univ Bath |
Modulators of tight junction permeability
|
KR20230125802A
(ko)
|
2020-12-11 |
2023-08-29 |
아이피2아이피오 이노베이션스 리미티드 |
신규 화합물
|
CN113398089A
(zh)
*
|
2021-06-29 |
2021-09-17 |
海南通用三洋药业有限公司 |
一种尼麦角林胶囊的制备方法和尼麦角林胶囊
|
CN115068435B
(zh)
*
|
2022-08-03 |
2023-04-25 |
昆山龙灯瑞迪制药有限公司 |
一种尼麦角林片的制备方法
|